• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. PDS PLATE UNKNOWN PRODUCT; POLYMER, EAR, NOSE AND THROAT, SYNTHETIC, ABSORBABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. PDS PLATE UNKNOWN PRODUCT; POLYMER, EAR, NOSE AND THROAT, SYNTHETIC, ABSORBABLE Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hematoma (1884)
Event Date 08/24/2021
Event Type  Injury  
Manufacturer Narrative
(b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.This report is related to a journal article; therefore, no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided.The single complaint was reported with multiple events.There are no additional details regarding the additional events.Related events reported via 2210968-2022-08465.Citation: the journal of craniofacial surgery volume 00, number 00, month 2021 https://doi.Org/10.1097/scs.0000000000008179.
 
Event Description
Title: a new technique of open septal reduction using polydioxanone plates for nasoseptal fracture: three- dimensional volumetric analysis.This retrospective study aims to compare a new technique for open septal reduction using a polydioxanone (pds) plate with closed reduction (cr) for nasoseptal fracture.From june 2017 to december 2019, we reviewed 19 consecutive patients with nasoseptal fractures who received surgery.The patients were divided into 2 groups: a cr group , with 7 males and 2 females, ( closed reduction (cr) group) and a polydioxanone (pds) plate group with 8 males and 2 females (pds group).The mean ages of the closed reduction (cr) group and polydioxanone (pds) plate group were 41 and 43.3 years, respectively.The procedure was performed with general anesthesia in all patients.First, cr was performed to correct nasal bone fracture using a blade handle and walsham forceps.In the pds group, the 0.25-mm-thick pds plate (pds flexible plate; ethicon, somerville, nj) was cut to about 2 cm height with scissors.In the last 7 patients, we made holes in the polydioxanone (pds) plate using a 1-mm punch biopsy device.The polydioxanone (pds) plate was placed beside the fractured septal cartilage horizontally above the vomerine suture.The polydioxanone (pds) plate was not inserted diagonally close to the dorsal septum to avoid narrowing of the internal valve due to the thickness of the polydioxanone (pds) plate.After insertion of the polydioxanone (pds) plate , it was fixed with 3-0 chromic mattress sutures through the full layers of the septum.The incision was closed with 4-0 chromic suture.Reported complications included: (n=1) septal hematoma was noted 3 months after surgery.Septal hematoma was resolved by needle aspiration and nasal packing.(n=1) figure 7.Clinical presentation 2.A 59-year-old woman who experienced exposure of a polydioxanone (pds) plate after it was used for open septal reduction.(a) preoperative photography revealed nasal deviation to the right side and loss of dorsal height.(b) although part of the polydioxanone (pds) plate was exposed and removed, as presented in figure 3, the nasal deviation and dorsal height were successfully recovered by cr of the nasal bone and open septal reduction using the polydioxanone (pds) plate.(c) there were septal deviation and discrepancy between the 2 sides on preoperative 3d volumetry.(d) the septal deviation was corrected after surgery.3d, three-dimensional; cr, closed reduction; pds, polydioxanone it was concluded ,that polydioxanone plates are effective stenting materials to reinforce the fractured septum in open septal reduction.When open septal reduction is performed using a polydioxanone (pds) plate, it is important to prevent complications when the polydioxanone (pds) plate is inserted to the concave side of septal deviation and is used with added perforations.In our experience, polydioxanone (pds) plate potentially present a new concept of open septal reduction in terms of septal reinforcement compared with the subtractive manner of open septal reduction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PDS PLATE UNKNOWN PRODUCT
Type of Device
POLYMER, EAR, NOSE AND THROAT, SYNTHETIC, ABSORBABLE
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.
Manufacturer Contact
elba bello
1000 route 202
raritan, NJ 08869
9083863534
MDR Report Key15614460
MDR Text Key301822790
Report Number2210968-2022-08464
Device Sequence Number1
Product Code NHB
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
K092590
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,User Facility
Reporter Occupation Other
Type of Report Initial
Report Date 10/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/17/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received10/05/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-